Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid–enhanced MRI in transplantation candidates

[1] Villanueva A(2019)Hepatocellular carcinoma N Engl J Med 380 1450-1462

[2] Clavien PA(2012)Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 e11-e22

[3] Lesurtel M(2013)New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma Radiology 266 376-382

[4] Bossuyt PM(2019)Is it time to expand the definition of washout appearance in LI-RADS? Radiology 291 658-659

[5] Gores GJ(2019)Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update Clin Mol Hepatol 25 245-263

[6] Langer B(2017)Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Hepatol Int 11 317-370

[7] Perrier A(2018)Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Hepatology 68 723-750

[8] Wald C(2018)AASLD guidelines for the treatment of hepatocellular carcinoma Hepatology 67 358-380

[9] Russo MW(2019)Emerging role of Hepatobiliary magnetic resonance contrast media and contrast-enhanced ultrasound for noninvasive diagnosis of hepatocellular carcinoma: emphasis on recent updates in major guidelines Korean J Radiol 20 863-879

[10] Heimbach JK(2015)Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis Radiology 275 97-109

[1] Villanueva A(2019)Hepatocellular carcinoma N Engl J Med 380 1450-1462

[2] Clavien PA(2012)Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 e11-e22

[3] Lesurtel M(2013)New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma Radiology 266 376-382

[4] Bossuyt PM(2019)Is it time to expand the definition of washout appearance in LI-RADS? Radiology 291 658-659

[5] Gores GJ(2019)Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update Clin Mol Hepatol 25 245-263

[6] Langer B(2017)Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update Hepatol Int 11 317-370

[7] Perrier A(2018)Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases Hepatology 68 723-750

[8] Wald C(2018)AASLD guidelines for the treatment of hepatocellular carcinoma Hepatology 67 358-380

[9] Russo MW(2019)Emerging role of Hepatobiliary magnetic resonance contrast media and contrast-enhanced ultrasound for noninvasive diagnosis of hepatocellular carcinoma: emphasis on recent updates in major guidelines Korean J Radiol 20 863-879

[10] Heimbach JK(2015)Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis Radiology 275 97-109